AIG
CNCR

American International Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

American International Group’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$6K – 5037
2015
Q4 		$6K Buy
+200
New +$5.75K ﹤0.01% 4650

Other funds holding CNCR

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

American International Group's CNCR Position: Q1 2016 in Review

American International Group sold out of ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) in Q1 2016, closing a stake of 200 shares — an estimated $6K sold.

American International Group first reported a position in CNCR in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 11 funds tracked by Wall St. Rank hold CNCR as of Q1 2016.

  • American International Group reported no remaining ETF Series Solutions Trust Range Cancer Therapeutics ETF position as of Q1 2016 after selling out during the quarter.
  • American International Group sold 200 ETF Series Solutions Trust Range Cancer Therapeutics ETF shares in Q1 2016, an estimated $6K.
  • American International Group first reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q4 2015 and held it in 1 quarter.
  • American International Group's ETF Series Solutions Trust Range Cancer Therapeutics ETF position peaked at $6K in Q4 2015.
  • 11 funds tracked by Wall St. Rank held ETF Series Solutions Trust Range Cancer Therapeutics ETF as of Q1 2016.

Based on American International Group's 13F filing for Q1 2016, filed 12 May 2016.